News
A successful second edition of the Defence Workshop
On Tuesday 11 February and Wednesday 12 February BarentsKrans was host of the second edition of the Defence Workshop. With participants and speakers from 13 different countries with a special interest in the Aerospace & Defence sector the workshop provided an international platform for the exchange of knowledge, contacts and experience in the sector. The
Read more ›
Telecoms Update | Court of Appeal injuncts Wiko and Asustek for infringement of SEP
On 24 December 2019 the The Hague Court of Appeal handed down its latest judgments in the SEP injunctive relief proceedings initiated by Philips against Wiko and Asustek respectively. This is the closing chapter in a series of proceedings whereby Philips sought to enforce three SEPs, two of which were held valid and infringed and
Read more ›
BarentsKrans advised Sparkling Biomass on investment by Primco
BarentsKrans advised the founders of Sparkling Biomass on the sale of 75% of the shares in the capital of this company to private equity investor Primco. As a result a joint venture has been created between Primco and the founders. Sparkling Biomass is in the process of building a bio-energy plant. The 15 MW plant’s
Read more ›
Telecoms update | Provisions judge denies Fractus a preliminary injunction against Xiaomi et al.
On 10 December 2019, the Provisions Judge of the District Court of The Hague denied a cross-border preliminary injunction claimed by FRACTUS S.A. (‘Fractus’) against Xiaomi Technology Netherlands B.V. (‘Xiaomi’) and several Dutch smartphone vendors for the alleged infringement of Fractus’ patent EP 1 592 083 (‘EP ‘083’). According to Fractus the antennas of various
Read more ›
Pharma Update | Tadalafil dose patent invalid: Court of Appeal confirms judgment 1st instance
The Court of Appeal of The Hague has confirmed the judgment in first instance, in which ICOS’ patent EP 1 173 181 B3 (‘EP ‘181’), claiming a 1-5 mg dosage range for tadalafil, was invalidated. EP ‘181 relates to tadalafil for the treatment of erectile dysfunction in a specific (low) dosage range. This finding was
Read more ›
Application of Skanska by the Arnhem-Leeuwarden Court of Appeal
On 26 November the Arnhem-Leeuwarden Court of Appeal applied the Skanska judgment of the ECJ to establish liability of a subsidiary for damages as a result of a breach of EU competition law (link). The decision stems from a follow-on damages action of TenneT in the gas-insulated switch gear cartel. In these proceedings TenneT not
Read more ›
BarentsKrans acts as independent advisor in relation to the investment in NewCompliance
BarentsKrans has acted as independent advisor for NewCompliance B.V., its founders and investors InnovationQuarter and Noaber Ventures during this transaction. BarentsKrans often acts as independent advisor in order to ensure that the transaction process is efficient and smooth. The scale-up NewCompliace has obtained an investment of USD 3 million to finance its expansion to the
Read more ›
BarentsKrans advises on the sell side of the acquisition of Dearnova
BarentsKrans has advised on the sell side of the acquisition of Dearnova by We are you. Dearnova has been incorporated in 2000 and currently employs over 70 professionals. The digital agency helps top players within the Netherlands such as PostNL, VodafoneZiggo, Schiphol and Telegraaf Media Groep. Each a top player in a different segment. We
Read more ›
BarentsKrans advises on the sell side of the acquisition of Royal Sens
BarentsKrans has advised on the sell side of the acquisition of Royal Sens by private equity firm Quadrum Capital. Quadrum Capital is a nationally operating investment company with offices in central and eastern Netherlands. Quadrum Capital has a strong entrepreneurial mentality and a broad portfolio of investments in various sectors. The packaging industry is one
Read more ›
The Dutch Authority for the Financial Markets (AFM) and the Dutch Central Bank (DNB) identify best practices for alternative interest rate benchmarks
From 1 January 2022 onwards, the Benchmark Regulation (2016/1011/EU) will be directly applicable in each member state of the European Union. As a result, certain crucial interest rate benchmarks, such as EURIBOR, LIBOR and EONIA, shall not be admissible in its current form. From that point on, new financial agreements and, in principle, also existing
Read more ›
